Analysts expect Microbot Medical Inc. to report revenue of 1.44 M for Q2 27, against a range of 1.37 M to 1.51 M.
| Metric | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | - | - | - | - | - | - | - | |||||||
| High Estimate | 1.51 M | 1.72 M | 1.63 M | 3.04 M | 6.45 M | 6.83 M | 6.70 M | 9.69 M | |||||||
| Low Estimate | 1.37 M | 1.48 M | 1.47 M | 2.83 M | 5.60 M | 6.02 M | 6.27 M | 8.32 M | |||||||
| Consensus Estimate | 1.44 M | 1.60 M | 1.55 M | 2.94 M | 6.03 M | 6.43 M | 6.49 M | 9.00 M |
Analysts expect Microbot Medical Inc. to report earnings per share of -0.08 for Q3 26, against a range of -0.08 to -0.08. The most recent reported quarter, Q2 26, came in at -0.08 , in line with the -0.08 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.20 | -0.19 | -0.08 | -0.10 | -0.07 | -0.05 | -0.05 | -0.08 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.16 | -0.18 | -0.11 | -0.08 | -0.06 | -0.06 | -0.07 | -0.08 | -0.08 | -0.09 | -0.08 | -0.10 | -0.07 | -0.07 | -0.07 | -0.08 | ||||||||||
| Low Estimate | -0.20 | -0.20 | -0.13 | -0.08 | -0.06 | -0.06 | -0.09 | -0.08 | -0.08 | -0.09 | -0.08 | -0.10 | -0.07 | -0.07 | -0.07 | -0.08 | ||||||||||
| Consensus Estimate | -0.18 | -0.19 | -0.12 | -0.08 | -0.06 | -0.06 | -0.08 | -0.08 | -0.08 | -0.09 | -0.08 | -0.10 | -0.07 | -0.07 | -0.07 | -0.08 |